AbbVie Inc (ABBV)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 9,137,000 | 12,757,000 | 18,117,000 | 17,924,000 | 11,363,000 |
| Revenue | US$ in thousands | 56,334,000 | 54,318,000 | 58,054,000 | 56,197,000 | 45,804,000 |
| Operating profit margin | 16.22% | 23.49% | 31.21% | 31.89% | 24.81% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $9,137,000K ÷ $56,334,000K
= 16.22%
The operating profit margin of AbbVie Inc has displayed a fluctuating trend over the past five years. Starting at 24.81% on December 31, 2020, it increased to 31.89% by December 31, 2021, showing a positive momentum. However, in the subsequent year, the margin slightly decreased to 31.21% on December 31, 2022.
Following this, the operating profit margin experienced a more significant decline, dropping to 23.49% by December 31, 2023, indicating a potential challenge in maintaining profitability. The downward trend continued as of December 31, 2024, with the margin declining further to 16.22%, marking a notable decrease compared to the previous years.
Overall, the decreasing trend in AbbVie Inc's operating profit margin from 2022 to 2024 suggests a need for the company to closely monitor and address factors impacting profitability to ensure sustainable financial performance in the future.
Peer comparison
Dec 31, 2024